LPT 25 mg Pill - brown capsule/oblong
Pill with imprint LPT 25 mg is Brown, Capsule/Oblong and has been identified as Topiramate Extended-Release 25 mg. It is supplied by Vitruvias Therapeutics, Inc.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LPT 25 mg
Topiramate Extended-Release
- Imprint
- LPT 25 mg
- Strength
- 25 mg
- Color
- Brown (opaque light brown)
- Shape
- Capsule/Oblong (capsule)
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Vitruvias Therapeutics, Inc.
- National Drug Code (NDC)
- 69680-0177
Related images for "LPT 25 mg"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,332)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
- Topiramate drug information
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Other brands
Topamax, Trokendi XR, Eprontia, Topiragen, Qudexy XR
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.